مهارکننده استیل‌کولین استراز (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "مهارکننده استیل‌کولین استراز" in Persian language version.

refsWebsite

Global rank Persian rank

27nih.gov

4^th place

5^th place

20doi.org

2^nd place

3worldcat.org

5^th place

12^th place

1england.nhs.uk

low place

1books.google.com

3^rd place

6^th place

1archive.org

6^th place

9^th place

1web.archive.org

1^st place

1mayoclinic.com

3,634^th place

1,633^rd place

1rsc.org

2,020^th place

2,657^th place

archive.org

Karadsheh N, Kussie P, Linthicum DS (March 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters. 55 (3): 335–42. doi:10.1016/0378-4274(91)90015-X. PMID 2003276.

books.google.com

Seth (2009-11-18). "23". Textbook Of Pharmacology. Elsevier India. p. III.87. ISBN 978-8131211588. Retrieved June 18, 2019. Anaesthesia: Cholinesterase inhibitors are likely to exaggerate succinylcholine-type muscle relaxation during anaesthesia. 5. Genitourinary system: It may ...

doi.org

English, Brett A.; Webster, Andrew A. (2012). "Acetylcholinesterase and its Inhibitors". Primer on the Autonomic Nervous System. Elsevier. pp. 631–633. doi:10.1016/b978-0-12-386525-0.00132-3. ISBN 978-0-12-386525-0.
English, Brett A.; Webster, Andrew A. (2012). "Acetylcholinesterase and its Inhibitors". Primer on the Autonomic Nervous System. Elsevier. pp. 631–633. doi:10.1016/b978-0-12-386525-0.00132-3. ISBN 978-0-12-386525-0.
English, Brett A.; Webster, Andrew A. (2012). "Acetylcholinesterase and its Inhibitors". Primer on the Autonomic Nervous System. Elsevier. pp. 631–633. doi:10.1016/b978-0-12-386525-0.00132-3. ISBN 978-0-12-386525-0.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. Bentham Science Publishers Ltd. 11 (3): 315–35. doi:10.2174/1570159x11311030006. PMC 3648782. PMID 24179466.
McGleenon BM, Dynan KB, Passmore AP (October 1999). "Acetylcholinesterase inhibitors in Alzheimer's disease". British Journal of Clinical Pharmacology. 48 (4): 471–80. doi:10.1046/j.1365-2125.1999.00026.x. PMC 2014378. PMID 10583015.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. 11 (3): 315–35. doi:10.2174/1570159X11311030006. PMC 3648782. PMID 24179466.
Singh J, Kour K, Jayaram MB (January 2012). "Acetylcholinesterase inhibitors for schizophrenia". The Cochrane Database of Systematic Reviews. 1: CD007967. doi:10.1002/14651858.CD007967.pub2. PMC 6823258. PMID 22258978.
Choi KH, Wykes T, Kurtz MM (September 2013). "Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy". The British Journal of Psychiatry. 203 (3): 172–8. doi:10.1192/bjp.bp.111.107359. PMC 3759029. PMID 23999481.
Ribeiz SR, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CM (April 2010). "Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature". CNS Drugs. 24 (4): 303–17. doi:10.2165/11530260-000000000-00000. PMID 20297855.
Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S, Swedo S (August 2011). "An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders". Journal of Child and Adolescent Psychopharmacology. 21 (4): 353–7. doi:10.1089/cap.2010.0121. PMC 3157749. PMID 21851192.
Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY (February 2011). "Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures". Journal of Child and Adolescent Psychopharmacology. 21 (1): 43–50. doi:10.1089/cap.2010.0024. PMC 3037196. PMID 21309696.
Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry. International Society for Neurochemistry (Wiley). 142: 73–81. doi:10.1111/jnc.13990. ISSN 0022-3042.
Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry. International Society for Neurochemistry (Wiley). 142: 73–81. doi:10.1111/jnc.13990. ISSN 0022-3042.
Karadsheh N, Kussie P, Linthicum DS (March 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters. 55 (3): 335–42. doi:10.1016/0378-4274(91)90015-X. PMID 2003276.
Vladimir-Knežević S, Blažeković B, Kindl M, Vladić J, Lower-Nedza AD, Brantner AH (January 2014). "Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family". Molecules. 19 (1): 767–82. doi:10.3390/molecules19010767. PMC 6271370. PMID 24413832.
Miyazawa M, Yamafuji C (March 2005). "Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids". Journal of Agricultural and Food Chemistry. 53 (5): 1765–8. doi:10.1021/jf040019b. PMID 15740071.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK (July 2000). "In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes". The Journal of Pharmacy and Pharmacology. 52 (7): 895–902. doi:10.1211/0022357001774598. PMID 10933142.
Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ (April 2009). "Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis". Journal of Neural Transmission. 116 (4): 457–65. doi:10.1007/s00702-009-0189-x. PMID 19221692.
Rhee IK, Appels N, Hofte B, Karabatak B, Erkelens C, Stark LM, Flippin LA, Verpoorte R (November 2004). "Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system". Biological & Pharmaceutical Bulletin. 27 (11): 1804–9. doi:10.1248/bpb.27.1804. PMID 15516727.
Messerer, Regina; Dallanoce, Clelia; Matera, Carlo; Wehle, Sarah; Flammini, Lisa; Chirinda, Brian; Bock, Andreas; Irmen, Matthias; Tränkle, Christian (2017-06-21). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm (به انگلیسی). 8 (6): 1346–1359. doi:10.1039/C7MD00149E. ISSN 2040-2511. PMC 6072511. PMID 30108847.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

england.nhs.uk

"Medications for treating people with dementia" (PDF). Retrieved 1 January 2021.

mayoclinic.com

Bauer, Brent A. "Huperzine A: Can it treat Alzheimer's?". Mayo Clinic. Archived from the original on 2012-08-19.

nih.gov

pubmed.ncbi.nlm.nih.gov

Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. Bentham Science Publishers Ltd. 11 (3): 315–35. doi:10.2174/1570159x11311030006. PMC 3648782. PMID 24179466.
McGleenon BM, Dynan KB, Passmore AP (October 1999). "Acetylcholinesterase inhibitors in Alzheimer's disease". British Journal of Clinical Pharmacology. 48 (4): 471–80. doi:10.1046/j.1365-2125.1999.00026.x. PMC 2014378. PMID 10583015.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. 11 (3): 315–35. doi:10.2174/1570159X11311030006. PMC 3648782. PMID 24179466.
Singh J, Kour K, Jayaram MB (January 2012). "Acetylcholinesterase inhibitors for schizophrenia". The Cochrane Database of Systematic Reviews. 1: CD007967. doi:10.1002/14651858.CD007967.pub2. PMC 6823258. PMID 22258978.
Choi KH, Wykes T, Kurtz MM (September 2013). "Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy". The British Journal of Psychiatry. 203 (3): 172–8. doi:10.1192/bjp.bp.111.107359. PMC 3759029. PMID 23999481.
Ribeiz SR, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CM (April 2010). "Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature". CNS Drugs. 24 (4): 303–17. doi:10.2165/11530260-000000000-00000. PMID 20297855.
Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S, Swedo S (August 2011). "An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders". Journal of Child and Adolescent Psychopharmacology. 21 (4): 353–7. doi:10.1089/cap.2010.0121. PMC 3157749. PMID 21851192.
Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY (February 2011). "Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures". Journal of Child and Adolescent Psychopharmacology. 21 (1): 43–50. doi:10.1089/cap.2010.0024. PMC 3037196. PMID 21309696.
Inglis F (June 2002). "The tolerability and safety of cholinesterase inhibitors in the treatment of dementia". International Journal of Clinical Practice. Supplement (127): 45–63. PMID 12139367.
Singh, Ravneet; Sadiq, Nazia M. (2020), "Cholinesterase Inhibitors", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31335056, retrieved 2020-10-12
Karadsheh N, Kussie P, Linthicum DS (March 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters. 55 (3): 335–42. doi:10.1016/0378-4274(91)90015-X. PMID 2003276.
Vladimir-Knežević S, Blažeković B, Kindl M, Vladić J, Lower-Nedza AD, Brantner AH (January 2014). "Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family". Molecules. 19 (1): 767–82. doi:10.3390/molecules19010767. PMC 6271370. PMID 24413832.
Miyazawa M, Yamafuji C (March 2005). "Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids". Journal of Agricultural and Food Chemistry. 53 (5): 1765–8. doi:10.1021/jf040019b. PMID 15740071.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK (July 2000). "In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes". The Journal of Pharmacy and Pharmacology. 52 (7): 895–902. doi:10.1211/0022357001774598. PMID 10933142.
Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ (April 2009). "Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis". Journal of Neural Transmission. 116 (4): 457–65. doi:10.1007/s00702-009-0189-x. PMID 19221692.
Rhee IK, Appels N, Hofte B, Karabatak B, Erkelens C, Stark LM, Flippin LA, Verpoorte R (November 2004). "Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system". Biological & Pharmaceutical Bulletin. 27 (11): 1804–9. doi:10.1248/bpb.27.1804. PMID 15516727.
Messerer, Regina; Dallanoce, Clelia; Matera, Carlo; Wehle, Sarah; Flammini, Lisa; Chirinda, Brian; Bock, Andreas; Irmen, Matthias; Tränkle, Christian (2017-06-21). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm (به انگلیسی). 8 (6): 1346–1359. doi:10.1039/C7MD00149E. ISSN 2040-2511. PMC 6072511. PMID 30108847.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

ncbi.nlm.nih.gov

Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. Bentham Science Publishers Ltd. 11 (3): 315–35. doi:10.2174/1570159x11311030006. PMC 3648782. PMID 24179466.
McGleenon BM, Dynan KB, Passmore AP (October 1999). "Acetylcholinesterase inhibitors in Alzheimer's disease". British Journal of Clinical Pharmacology. 48 (4): 471–80. doi:10.1046/j.1365-2125.1999.00026.x. PMC 2014378. PMID 10583015.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (May 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology. 11 (3): 315–35. doi:10.2174/1570159X11311030006. PMC 3648782. PMID 24179466.
Singh J, Kour K, Jayaram MB (January 2012). "Acetylcholinesterase inhibitors for schizophrenia". The Cochrane Database of Systematic Reviews. 1: CD007967. doi:10.1002/14651858.CD007967.pub2. PMC 6823258. PMID 22258978.
Choi KH, Wykes T, Kurtz MM (September 2013). "Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy". The British Journal of Psychiatry. 203 (3): 172–8. doi:10.1192/bjp.bp.111.107359. PMC 3759029. PMID 23999481.
Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S, Swedo S (August 2011). "An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders". Journal of Child and Adolescent Psychopharmacology. 21 (4): 353–7. doi:10.1089/cap.2010.0121. PMC 3157749. PMID 21851192.
Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY (February 2011). "Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures". Journal of Child and Adolescent Psychopharmacology. 21 (1): 43–50. doi:10.1089/cap.2010.0024. PMC 3037196. PMID 21309696.
Singh, Ravneet; Sadiq, Nazia M. (2020), "Cholinesterase Inhibitors", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31335056, retrieved 2020-10-12
Vladimir-Knežević S, Blažeković B, Kindl M, Vladić J, Lower-Nedza AD, Brantner AH (January 2014). "Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family". Molecules. 19 (1): 767–82. doi:10.3390/molecules19010767. PMC 6271370. PMID 24413832.
Messerer, Regina; Dallanoce, Clelia; Matera, Carlo; Wehle, Sarah; Flammini, Lisa; Chirinda, Brian; Bock, Andreas; Irmen, Matthias; Tränkle, Christian (2017-06-21). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm (به انگلیسی). 8 (6): 1346–1359. doi:10.1039/C7MD00149E. ISSN 2040-2511. PMC 6072511. PMID 30108847.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

rsc.org

pubs.rsc.org

Messerer, Regina; Dallanoce, Clelia; Matera, Carlo; Wehle, Sarah; Flammini, Lisa; Chirinda, Brian; Bock, Andreas; Irmen, Matthias; Tränkle, Christian (2017-06-21). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm (به انگلیسی). 8 (6): 1346–1359. doi:10.1039/C7MD00149E. ISSN 2040-2511. PMC 6072511. PMID 30108847.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

web.archive.org

Bauer, Brent A. "Huperzine A: Can it treat Alzheimer's?". Mayo Clinic. Archived from the original on 2012-08-19.

worldcat.org

Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry. International Society for Neurochemistry (Wiley). 142: 73–81. doi:10.1111/jnc.13990. ISSN 0022-3042.
Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry. International Society for Neurochemistry (Wiley). 142: 73–81. doi:10.1111/jnc.13990. ISSN 0022-3042.
Messerer, Regina; Dallanoce, Clelia; Matera, Carlo; Wehle, Sarah; Flammini, Lisa; Chirinda, Brian; Bock, Andreas; Irmen, Matthias; Tränkle, Christian (2017-06-21). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm (به انگلیسی). 8 (6): 1346–1359. doi:10.1039/C7MD00149E. ISSN 2040-2511. PMC 6072511. PMID 30108847.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)